[
  {
    "ts": "2025-11-19T04:37:49+00:00",
    "headline": "2 High-Flying Stocks with Exciting Potential and 1 We Find Risky",
    "summary": "Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.",
    "url": "https://finance.yahoo.com/news/2-high-flying-stocks-exciting-043749835.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "c11ccaa5-ba21-39b0-a520-3d4f318ffe6f",
      "content": {
        "id": "c11ccaa5-ba21-39b0-a520-3d4f318ffe6f",
        "contentType": "STORY",
        "title": "2 High-Flying Stocks with Exciting Potential and 1 We Find Risky",
        "description": "",
        "summary": "Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.",
        "pubDate": "2025-11-19T04:37:49Z",
        "displayTime": "2025-11-19T04:37:49Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f8bb661384c98a14c4860c2f1ba766e2",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "FUBO Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FnmCtA78.T8b4V1wqvltsw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f8bb661384c98a14c4860c2f1ba766e2.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xsAGq2mQL32hUtc9rc.dAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f8bb661384c98a14c4860c2f1ba766e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/2-high-flying-stocks-exciting-043749835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-high-flying-stocks-exciting-043749835.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "FUBO"
            },
            {
              "symbol": "RBC"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-19T08:47:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights Microsoft, Amazon.com and Eli Lilly",
    "summary": "Microsoft posts strong cloud-fueled Q1 results as Azure surges and AI momentum builds, even as capacity limits pose near-term revenue constraints.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-084700571.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "720f4296-cd87-3de7-99f3-426c703d1e06",
      "content": {
        "id": "720f4296-cd87-3de7-99f3-426c703d1e06",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights Microsoft, Amazon.com and Eli Lilly",
        "description": "",
        "summary": "Microsoft posts strong cloud-fueled Q1 results as Azure surges and AI momentum builds, even as capacity limits pose near-term revenue constraints.",
        "pubDate": "2025-11-19T08:47:00Z",
        "displayTime": "2025-11-19T08:47:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_em.9ncGoJjUS4ORBdaZw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mvTEQT49jmd3kudPY9tlfw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-084700571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-084700571.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-19T12:11:11+00:00",
    "headline": "Novo Nordisk (NVO) To Lower US Prices of its Injectable Wegovy Obesity Drug",
    "summary": "​Novo Nordisk A/S (NYSE:NVO) is one of the Most Profitable Stocks to Buy Now. On November 17, Reuters reported that Novo Nordisk A/S (NYSE:NVO) will lower the US prices of its injectable Wegovy obesity drug. The price reduction for injectable Wegovy follows the company’s earlier announcement on November 6, where it agreed with the US […]",
    "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-lower-us-121111158.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a065ebdf-cf4d-390c-b0a2-70076b43e1cc",
      "content": {
        "id": "a065ebdf-cf4d-390c-b0a2-70076b43e1cc",
        "contentType": "STORY",
        "title": "Novo Nordisk (NVO) To Lower US Prices of its Injectable Wegovy Obesity Drug",
        "description": "",
        "summary": "​Novo Nordisk A/S (NYSE:NVO) is one of the Most Profitable Stocks to Buy Now. On November 17, Reuters reported that Novo Nordisk A/S (NYSE:NVO) will lower the US prices of its injectable Wegovy obesity drug. The price reduction for injectable Wegovy follows the company’s earlier announcement on November 6, where it agreed with the US […]",
        "pubDate": "2025-11-19T12:11:11Z",
        "displayTime": "2025-11-19T12:11:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8ee01456c2860ad756980e44c064cbb6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Q4WZ5Bxu2dV2RSuekCnYOA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8ee01456c2860ad756980e44c064cbb6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Wtv9b7DPXjUACIx2mcDwGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8ee01456c2860ad756980e44c064cbb6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-lower-us-121111158.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-nvo-lower-us-121111158.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-19T11:45:00+00:00",
    "headline": "Breakthrough Properties and Eli Lilly and Company Partner to Bring Lilly Gateway Labs to Newly-Developed 2300 Market Street in Philadelphia",
    "summary": "Breakthrough Properties today announced that it has partnered with Eli Lilly and Company (Lilly) to launch Lilly Gateway Labs at Breakthrough at 2300 Market Street in Philadelphia. This new partnership provides innovative biotech companies comprehensive access to move-in ready labs, fully-equipped workspaces, and amenities they need to succeed and grow.",
    "url": "https://finance.yahoo.com/news/breakthrough-properties-eli-lilly-company-114500126.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "21498e0d-52c7-345a-aa77-67ddef5fdfe3",
      "content": {
        "id": "21498e0d-52c7-345a-aa77-67ddef5fdfe3",
        "contentType": "STORY",
        "title": "Breakthrough Properties and Eli Lilly and Company Partner to Bring Lilly Gateway Labs to Newly-Developed 2300 Market Street in Philadelphia",
        "description": "",
        "summary": "Breakthrough Properties today announced that it has partnered with Eli Lilly and Company (Lilly) to launch Lilly Gateway Labs at Breakthrough at 2300 Market Street in Philadelphia. This new partnership provides innovative biotech companies comprehensive access to move-in ready labs, fully-equipped workspaces, and amenities they need to succeed and grow.",
        "pubDate": "2025-11-19T11:45:00Z",
        "displayTime": "2025-11-19T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/339f73830ceb1a50239eb6a8d46419d6",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "Lilly Gateway Labs at Breakthrough – Image by Sahar Coston-Hardy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A4AmxrmvfIOO870I9XrHhg--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/339f73830ceb1a50239eb6a8d46419d6.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jZ2aGa.xR0bZG7Ay8ue8Og--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/339f73830ceb1a50239eb6a8d46419d6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/breakthrough-properties-eli-lilly-company-114500126.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/breakthrough-properties-eli-lilly-company-114500126.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-19T11:45:00+00:00",
    "headline": "Lilly announces plans to open Lilly Gateway Labs site in Philadelphia",
    "summary": "Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing its distinctive model of scientific partnership to a city known for shaping the future of medicine.",
    "url": "https://finance.yahoo.com/news/lilly-announces-plans-open-lilly-114500311.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "df7b15e8-0f2d-3f34-bf13-6db9117a3e15",
      "content": {
        "id": "df7b15e8-0f2d-3f34-bf13-6db9117a3e15",
        "contentType": "STORY",
        "title": "Lilly announces plans to open Lilly Gateway Labs site in Philadelphia",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing its distinctive model of scientific partnership to a city known for shaping the future of medicine.",
        "pubDate": "2025-11-19T11:45:00Z",
        "displayTime": "2025-11-19T11:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/ad7af50e3735a7b0f0f91c8ee7b3ca16",
          "originalWidth": 400,
          "originalHeight": 217,
          "caption": "Lilly announces plans to open Lilly Gateway Labs site in Philadelphia",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Mzhq.1LB8b.gJTkTVt8yLA--~B/aD0yMTc7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ad7af50e3735a7b0f0f91c8ee7b3ca16.cf.webp",
              "width": 400,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aGFCe_8rU4iIeKShtMSpHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ad7af50e3735a7b0f0f91c8ee7b3ca16.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lilly-announces-plans-open-lilly-114500311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-announces-plans-open-lilly-114500311.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-19T11:05:00+00:00",
    "headline": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
    "summary": "These stocks both have advanced in the double-digits in recent months.",
    "url": "https://www.fool.com/investing/2025/11/19/missed-out-on-lilly-2-healthcare-stocks-to-buy/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "0a992053-eff9-32cb-acf7-1977f1529ad6",
      "content": {
        "id": "0a992053-eff9-32cb-acf7-1977f1529ad6",
        "contentType": "STORY",
        "title": "Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.",
        "description": "",
        "summary": "These stocks both have advanced in the double-digits in recent months.",
        "pubDate": "2025-11-19T11:05:00Z",
        "displayTime": "2025-11-19T11:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/6c2415d7dcea70333faa524027b769ec",
          "originalWidth": 1400,
          "originalHeight": 858,
          "caption": "Investors look at something on a computer screen in an office.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QLYdVyRAlIaRt0g9pX4hxA--~B/aD04NTg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/6c2415d7dcea70333faa524027b769ec.cf.webp",
              "width": 1400,
              "height": 858,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cgJp09IWXdA2p_q3ptA7SQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/6c2415d7dcea70333faa524027b769ec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/19/missed-out-on-lilly-2-healthcare-stocks-to-buy/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/missed-eli-lilly-2-healthcare-110500718.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]